These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36428889)

  • 1. Fuzzy-Based PROMETHEE Method for Performance Ranking of SARS-CoV-2 IgM Antibody Tests.
    Arikan A; Sanlidag T; Sayan M; Uzun B; Uzun Ozsahin D
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques.
    Sayan M; Sarigul Yildirim F; Sanlidag T; Uzun B; Uzun Ozsahin D; Ozsahin I
    Comput Math Methods Med; 2020; 2020():1560250. PubMed ID: 32802146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive colloidal gold-based immunochromatographic strip assay reactions for antibodies to SARS-CoV-2 in patients with autoimmune diseases.
    Xiao X; Zhou Q; Zhu J; Sun L; Zhang H; Sun Y; Zhao J; Cui L
    Ann Transl Med; 2021 Apr; 9(7):534. PubMed ID: 33987232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test.
    Kulkarni R; Shrivastava S; Patil HP; Kore P; Rane P; Palkar S; Lalwani S; Mishra AC; Arankalle VA
    Indian J Med Res; 2021 May; 153(5&6):658-664. PubMed ID: 34145085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of UTI Diagnostic Techniques Using the Fuzzy-PROMETHEE Model.
    Abobakr M; Uzun B; Uzun Ozsahin D; Sanlidag T; Arikan A
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the new easy approach to fuzzy multi-criteria decision aid in the field of management.
    Ziemba P
    MethodsX; 2021; 8():101344. PubMed ID: 34430248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative approach for ranking contaminated sites based on the risk assessment paradigm using fuzzy PROMETHEE.
    Zhang K; Kluck C; Achari G
    Environ Manage; 2009 Nov; 44(5):952-67. PubMed ID: 19763684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PROMETHEE based outranking approach for the construction of Fangcang shelter hospital using spherical fuzzy sets.
    Akram M; Zahid K; Kahraman C
    Artif Intell Med; 2023 Jan; 135():102456. PubMed ID: 36628791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients].
    Dinç HÖ; Özdemir YE; Alkan S; Güngördü Dalar Z; Gareayaghi N; Sirekbasan S; Tuyji Tok Y; Kuşkucu MA; Karaali R; Özbey D; Aygün G; Midilli K; Kocazeybek B
    Mikrobiyol Bul; 2021 Apr; 55(2):207-222. PubMed ID: 33882652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.
    Meng QB; Peng JJ; Wei X; Yang JY; Li PC; Qu ZW; Xiong YF; Wu GJ; Hu ZM; Yu JC; Su W
    World J Clin Cases; 2020 Oct; 8(19):4360-4369. PubMed ID: 33083395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
    Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
    Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
    Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
    BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.